Research Article
Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
Table 3
Long noncoding RNA-TUG1 expression w.r.t clinicopathological features.
| Variables | Long noncoding RNA-TUG1 | value | Mean | SD |
| Relative expression | 7.64 | 5.50 | — | Age | | | | ≤50 years | 8.01 | 7.06 | 0.58 | >50 years | 7.21 | 2.74 | Menopause | | | | Yes | 7.83 | 5.84 | 0.55 | No | 7.27 | 4.82 | Lymph nodes | | | | Yes | 7.28 | 3.21 | 0.62 | No | 7.93 | 6.80 | ER status | | | | Yes | 7.01 | 2.89 | 0.95 | No | 7.93 | 6.34 | PR status | | | | Yes | 6.95 | 2.42 | 0.93 | No | 7.91 | 6.30 | Her2 status | | | | Yes | 8.04 | 4.46 | 0.26 | No | 7.38 | 6.12 | TNM stages | | | | Early stage (I & II) | 8.45 | 8.00 | 0.06 | Advanced stage (III&IV) | 7.42 | 2.41 | Distant metastases | | | | Yes | 7.86 | 2.41 | 0.12 | No | 7.58 | 6.18 |
|
|